These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11408251)

  • 1. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers.
    Carrière F; Renou C; Ransac S; Lopez V; De Caro J; Ferrato F; De Caro A; Fleury A; Sanwald-Ducray P; Lengsfeld H; Beglinger C; Hadvary P; Verger R; Laugier R
    Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G16-28. PubMed ID: 11408251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals.
    Carrière F; Renou C; Lopez V; De Caro J; Ferrato F; Lengsfeld H; De Caro A; Laugier R; Verger R
    Gastroenterology; 2000 Oct; 119(4):949-60. PubMed ID: 11040182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin, THL) in the stomach and small intestine.
    Sternby B; Hartmann D; Borgström B; Nilsson A
    Clin Nutr; 2002 Oct; 21(5):395-402. PubMed ID: 12381337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis.
    Point V; Bénarouche A; Zarrillo J; Guy A; Magnez R; Fonseca L; Raux B; Leclaire J; Buono G; Fotiadu F; Durand T; Carrière F; Vaysse C; Couëdelo L; Cavalier JF
    Eur J Med Chem; 2016 Nov; 123():834-848. PubMed ID: 27543878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor.
    Borovicka J; Schwizer W; Guttmann G; Hartmann D; Kosinski M; Wastiel C; Bischof-Delaloye A; Fried M
    Gut; 2000 Jun; 46(6):774-81. PubMed ID: 10807887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects.
    Enç FY; Ones T; Akin HL; Dede F; Turoğlu HT; Ulfer G; Bekiroğlu N; Haklar G; Rehfeld JF; Holst JJ; Ulusoy NB; Imeryüz N
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G482-9. PubMed ID: 19109408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions.
    Di Marco M; Marier JF; Ducharme MP; Morin I; Engel C; Gulbranson S; Thudi NR; Murpani D; Rampal A; Monif T; Koundinya TS; Deo K; Monif T
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):319-26. PubMed ID: 18541129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of lipase inhibition by orlistat on gastric emptying and orocecal transit time of a solid meal.
    Kocełak P; Zahorska-Markiewicz B; Jonderko K; Olszanecka-Glinianowicz M; Zak-Gołab A; Holecki M; Kamińska M; Szymszal M
    J Gastroenterol; 2008; 43(8):609-17. PubMed ID: 18709483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity.
    Joyce P; Dening TJ; Meola TR; Gustafsson H; Kovalainen M; Prestidge CA
    Eur J Pharm Sci; 2019 Jul; 135():1-11. PubMed ID: 31067495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract.
    Armand M; Pasquier B; André M; Borel P; Senft M; Peyrot J; Salducci J; Portugal H; Jaussan V; Lairon D
    Am J Clin Nutr; 1999 Dec; 70(6):1096-106. PubMed ID: 10584056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
    Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
    Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.
    Bryson A; de la Motte S; Dunk C
    Br J Clin Pharmacol; 2009 Mar; 67(3):309-15. PubMed ID: 19220279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size.
    Suter PM; Marmier G; Veya-Linder C; Hänseler E; Lentz J; Vetter W; Otvos J
    Atherosclerosis; 2005 May; 180(1):127-35. PubMed ID: 15823285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat.
    Hussain Y; Güzelhan C; Odink J; van der Beek EJ; Hartmann D
    J Clin Pharmacol; 1994 Nov; 34(11):1121-5. PubMed ID: 7876405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study.
    Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M
    Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal.
    Goedecke JH; Barsdorf M; Beglinger C; Levitt NS; Lambert EV
    Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1479-85. PubMed ID: 14634678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipase in the regulation of upper gastrointestinal function in humans.
    Schwizer W; Asal K; Kreiss C; Mettraux C; Borovicka J; Rémy B; Güzelhan C; Hartmann D; Fried M
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G612-20. PubMed ID: 9316463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the pancreas really produce much more lipase than required for fat digestion?
    Carrière F; Grandval P; Gregory PC; Renou C; Henniges F; Sander-Struckmeier S; Laugier R
    JOP; 2005 May; 6(3):206-15. PubMed ID: 15883471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans.
    Carriere F; Barrowman JA; Verger R; Laugier R
    Gastroenterology; 1993 Sep; 105(3):876-88. PubMed ID: 8359655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.